Emerging drugs for schizophrenia

Author： Biedermann Falko   Fleischhacker W Wolfgang  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.2, 2011-06, pp. : 271-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

By Heresco-Levy Uriel  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 827-844

Informa Healthcare

Access to resources Recommend Favorite

Novel Targets for Drugs in Schizophrenia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for focal epilepsy

By Mula Marco  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 87-95

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for neuroblastoma

By Castel Victoria  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 155-171

Informa Healthcare

Access to resources Recommend Favorite

Emerging antiobesity drugs

By Spanswick David   Lee Kevin  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 217-237

Informa Healthcare

Access to resources Recommend Favorite